Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 26, 2001
Combining multiple structure and sequence alignments to improve sequence detection and alignment: application to the SH2 domains of Janus kinases
B Al-Lazikani, F B Sheinerman, B Honig
Journal of Molecular Biology
|
February 12, 1998
Standard conformations for the canonical structures of immunoglobulins
B Al-Lazikani, A M Lesk, C Chothia
Journal of Molecular Biology
|
February 5, 2000
Canonical structures for the hypervariable regions of T cell alphabeta receptors
B Al-Lazikani, A M Lesk, C Chothia
Current Opinion in Chemical Biology
|
February 13, 2001
Protein structure prediction
B Al-Lazikani, J Jung, Z Xiang, et al.
Clinical Pharmacology and Therapeutics
|
January 31, 2013
Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance
D Gonzalez de Castro, P A Clarke, B Al-Lazikani, et al.
Oncogene
|
February 26, 2013
JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
Z S Walters, B Villarejo-Balcells, D Olmos, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Proceedings of the National Academy of Sciences of the United States of America
|
December 26, 2001
Combining multiple structure and sequence alignments to improve sequence detection and alignment: application to the SH2 domains of Janus kinases
B Al-Lazikani, F B Sheinerman, B Honig
Journal of Molecular Biology
|
February 12, 1998
Standard conformations for the canonical structures of immunoglobulins
B Al-Lazikani, A M Lesk, C Chothia
Journal of Molecular Biology
|
February 5, 2000
Canonical structures for the hypervariable regions of T cell alphabeta receptors
B Al-Lazikani, A M Lesk, C Chothia
Current Opinion in Chemical Biology
|
February 13, 2001
Protein structure prediction
B Al-Lazikani, J Jung, Z Xiang, et al.
Clinical Pharmacology and Therapeutics
|
January 31, 2013
Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance
D Gonzalez de Castro, P A Clarke, B Al-Lazikani, et al.
Oncogene
|
February 26, 2013
JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells
Z S Walters, B Villarejo-Balcells, D Olmos, et al.
Page
of 1